Home Cart 0 Sign in  
X

[ CAS No. 4265-16-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 4265-16-1
Chemical Structure| 4265-16-1
Chemical Structure| 4265-16-1
Structure of 4265-16-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 4265-16-1 ]

Related Doc. of [ 4265-16-1 ]

Alternatived Products of [ 4265-16-1 ]

Product Details of [ 4265-16-1 ]

CAS No. :4265-16-1 MDL No. :MFCD00015463
Formula : C9H6O2 Boiling Point : -
Linear Structure Formula :- InChI Key :ADDZHRRCUWNSCS-UHFFFAOYSA-N
M.W : 146.14 Pubchem ID :61341
Synonyms :

Calculated chemistry of [ 4265-16-1 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 41.6
TPSA : 30.21 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.52 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.49
Log Po/w (XLOGP3) : 2.35
Log Po/w (WLOGP) : 2.25
Log Po/w (MLOGP) : 0.88
Log Po/w (SILICOS-IT) : 2.56
Consensus Log Po/w : 1.91

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.77
Solubility : 0.25 mg/ml ; 0.00171 mol/l
Class : Soluble
Log S (Ali) : -2.62
Solubility : 0.347 mg/ml ; 0.00238 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.21
Solubility : 0.0895 mg/ml ; 0.000612 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.09

Safety of [ 4265-16-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 4265-16-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 4265-16-1 ]
  • Downstream synthetic route of [ 4265-16-1 ]

[ 4265-16-1 ] Synthesis Path-Upstream   1~24

  • 1
  • [ 271-89-6 ]
  • [ 68-12-2 ]
  • [ 4265-16-1 ]
YieldReaction ConditionsOperation in experiment
90% at 80℃; POCl3 (4.73 mL, 50.79 mmol) was slowly added to a solution of DMF (6.56 mL, 84.75 mmol) while the temperature was maintained below 40 °C. Then, benzofuran 1 (2.00 g,16.93 mol) was added dropwise to this reaction mixture below 40 °C, over a period of 15 min. The mixture was heated at 80 °C for 24 h. The reaction mixture was then poured into ice-water and carefully quenched with a solution of sodium hydroxide. The organic material was separated, and the aqueous layer was extracted with ethyl acetate. It was washed with brine and dried over anhydrous magnesium sulfate. The filtrate was concentrated, and was purified on silica gel column (petroleum ether: EtOAc = 10:1) to give product 2 (2.27 g, 90percent) as brown oil. 1H NMR (400 MHz,CDCl3): δ 9.83 (1H, s, COH), 7.75-7.70 (1H, m, H-4), 7.56-7.54 (2H, m, H-6,7), 7.46 (1H, s, H-3), 7.32-7.28 (1H, m, H-5). 13C NMR (100 MHz, CDCl3): δ 179.63 (COH), 156.03 (C-7a), 152.52 (C-2), 129.07 (C-3a), 126.51 (C-6), 124.05 (C-5), 123.58 (C-4), 117.93 (C-3), 112.44 (C-7).
80%
Stage #1: With n-butyllithium In tetrahydrofuran; hexane at -78℃; for 1 h;
Stage #2: at 20℃;
1. To a solution of benzofuran (1.5 g, 12.69 mmol) in 60 mL of THF, was added 5.08 mL(12.69 mmol) of n-BuLi solution in hexanes (2.5 M) at -78 °C. After 1 hr at -78 °C, the reaction mixture was added DMF (3.43 mL). After overnight at RT, the reaction was quenched with saturated ammonium chloride, and extracted with EtOAc (x3). The combined organic extracts were dried (MgS04), filtered, and concentrated. Flash chromatography (10 percentEtOAc/Hexanes) gave benzofuran-2-carbaldehyde (1.48 g, 80percent). *H NMR (400 MHz, CDC13) δ ppm: 9.88 (s, IH), 7.76 (d, J=8.4 Hz, IH), 7.62 (d, J=8.4 Hz, IH), 7.57 (s, IH), 7.52 (td, J=7.2, 1.2 Hz IH), 7.35 (td, J=7.2, 1.2 Hz, IH).
61%
Stage #1: With n-butyllithium; ammonium chloride In tetrahydrofuran; hexane at -78℃; for 0.5 h; Inert atmosphere
Stage #2: at -78℃; for 1 h;
Step 1:
benzofuran-2-carbaldehyde
To a solution of benzofuran (10 g, 84.7 mmol) in dry THF was added n-BuLi (2.5 M solution in hexane, 33.9 mL, 84.7 mmol) dropwise at -78° C. under nitrogen, the mixture was stirred at -78° C. for 0.5 h, and then added DMF (19.6 mL, 254 mmol).
The resulted mixture was kept at -78° C. and stirred for 1 h.
The reaction was quenched by addition of saturated NH4Cl aqueous solution (20 mL), and then added ethyl acetate (300 mL) and H2O (100 mL), the aqueous layer was extracted with ethyl acetate (50 mL).
The combined organic layer was washed with water and brine, dried over sodium sulfate and concentrated under vacuum, the residue was purified by column chromatography on silica gel (ethyl acetate:petroleum ether=10:1) to afford benzofuran-2-carbaldehyde (7.5 g, yield: 61percent) as yellow oil.
1H NMR (400 MHz, CDCl3): δ 9.90 (s, 1H), 7.78 (d, J=8.8 Hz, 1H), 7.63 (d, J=8.2 Hz, 1H), 7.59 (s, 1H), 7.53-7.57 (m, 1H), 7.35-7.39 (m, 1H).
40% at 80℃; Preparation of 2,3-Benzofuran-5-carboxaldehyde 39[0201] To a DMF (0.580 mL) solution of 2,3-benzofuran 38 (0.331 mL, 3.0 mmol) was added phosphorous oxychloride (0.302 mL, 3.3 mmol). The reaction mixture was stirred overnight at 80 °C, then the excess solvent was removed in vacuo. The residue was diluted with ethyl acetate (100 mL), then washed with water (2 X 20 mL). The organic layer was dried with brine and MgSC>4, then concentrated in vacuo. Flash column chromatography on silica gel (n-hexanes : ethyl acetate = 50:1) of the residue afforded the desired product 39 in 40percent yield (172 mg, yellow oil). LH NMR (400 MHz, CDC13): 9.88 (s, 1H), 7.76 (d, J= 7.2 Hz, 2H), 7.62 (dd, J= 8.4, 0.8 Hz, 1H), 7.54 (d, J= 0.8 Hz, 1H), 7.53 (td, J= 12, 1.2 Hz, 1H), 7.35 (td, J= 7.2, 0.8 Hz, 1H).

Reference: [1] Chemical Communications, 2017, vol. 53, # 54, p. 7545 - 7548
[2] Organic Letters, 2012, vol. 14, # 3, p. 844 - 847
[3] Letters in Drug Design and Discovery, 2014, vol. 11, # 8, p. 975 - 984
[4] ChemMedChem, 2017, vol. 12, # 3, p. 257 - 270
[5] Patent: WO2016/114816, 2016, A1, . Location in patent: Paragraph 0331
[6] Chemistry - A European Journal, 2006, vol. 12, # 10, p. 2739 - 2744
[7] Tetrahedron Asymmetry, 2008, vol. 19, # 4, p. 500 - 511
[8] Medicinal Chemistry Research, 2014, vol. 23, # 3, p. 1599 - 1611
[9] Patent: US2017/37038, 2017, A1, . Location in patent: Paragraph 0137; 0138; 0139
[10] Collection of Czechoslovak Chemical Communications, 1982, vol. 47, # 12, p. 3288 - 3296
[11] Patent: WO2011/130419, 2011, A2, . Location in patent: Page/Page column 49
[12] Journal of the Chemical Society, 1955, p. 3688,3692
[13] Indian Journal of Chemistry - Section B Organic Chemistry Including Medicinal Chemistry, 1989, vol. 28, # 5, p. 385 - 390
[14] Journal of Medicinal Chemistry, 2002, vol. 45, # 20, p. 4559 - 4570
[15] Phosphorus, Sulfur and Silicon and the Related Elements, 2008, vol. 183, # 1, p. 136 - 143
[16] Journal of Organic Chemistry, 2018,
  • 2
  • [ 55038-01-2 ]
  • [ 4265-16-1 ]
Reference: [1] Green Chemistry, 2012, vol. 14, # 5, p. 1493 - 1501
[2] Advanced Synthesis and Catalysis, 2016, vol. 358, # 7, p. 1157 - 1163
[3] Journal of the American Chemical Society, 2008, vol. 130, # 10, p. 2898 - 2899
[4] Angewandte Chemie - International Edition, 2015, vol. 54, # 14, p. 4241 - 4245
[5] European Journal of Organic Chemistry, 2015, vol. 2015, # 19, p. 4071 - 4076
[6] Chemische Berichte, 1988, vol. 121, p. 2259 - 2262
[7] Patent: US6420375, 2002, B1,
[8] European Journal of Organic Chemistry, 2014, vol. 2014, # 4, p. 772 - 780
[9] European Journal of Organic Chemistry, 2014, vol. 2014, # 4, p. 772 - 780
[10] Synlett, 2016, vol. 27, # 16, p. 2372 - 2377
[11] Organic Letters, 2017, vol. 19, # 11, p. 2865 - 2868
  • 3
  • [ 3199-61-9 ]
  • [ 4265-16-1 ]
Reference: [1] Organic and Biomolecular Chemistry, 2017, vol. 15, # 6, p. 1530 - 1536
[2] Journal of the Indian Chemical Society, 1980, vol. 57, # 6, p. 633 - 636
[3] Angewandte Chemie - International Edition, 2015, vol. 54, # 14, p. 4241 - 4245
[4] European Journal of Organic Chemistry, 2015, vol. 2015, # 19, p. 4071 - 4076
[5] Advanced Synthesis and Catalysis, 2016, vol. 358, # 7, p. 1157 - 1163
  • 4
  • [ 27064-03-5 ]
  • [ 4265-16-1 ]
Reference: [1] Organic Letters, 2017, vol. 19, # 7, p. 1646 - 1649
  • 5
  • [ 271-89-6 ]
  • [ 4265-16-1 ]
Reference: [1] Patent: US5037853, 1991, A,
[2] Patent: US5120752, 1992, A,
  • 6
  • [ 90-02-8 ]
  • [ 4265-16-1 ]
Reference: [1] European Journal of Medicinal Chemistry, 1983, vol. 18, # 4, p. 353 - 358
[2] Organic Letters, 2012, vol. 14, # 5, p. 1298 - 1301
[3] Chemistry - A European Journal, 2013, vol. 19, # 13, p. 4335 - 4343
[4] Angewandte Chemie - International Edition, 2015, vol. 54, # 14, p. 4241 - 4245
[5] European Journal of Organic Chemistry, 2015, vol. 2015, # 19, p. 4071 - 4076
[6] Medicinal Chemistry Research, 2016, vol. 25, # 3, p. 494 - 500
[7] Pharmaceutical Chemistry Journal, 2018, vol. 51, # 10, p. 893 - 901
[8] Advanced Synthesis and Catalysis, 2016, vol. 358, # 7, p. 1157 - 1163
[9] Organic and Biomolecular Chemistry, 2017, vol. 15, # 6, p. 1530 - 1536
[10] Journal of Molecular Structure, 2018, vol. 1153, p. 119 - 127
  • 7
  • [ 90-02-8 ]
  • [ 2032-35-1 ]
  • [ 4265-16-1 ]
Reference: [1] Patent: US4528282, 1985, A,
  • 8
  • [ 1646-26-0 ]
  • [ 4265-16-1 ]
Reference: [1] Angewandte Chemie - International Edition, 2013, vol. 52, # 43, p. 11303 - 11307[2] Angew. Chem., 2013, vol. 125, # 43, p. 11513 - 11517,5
  • 9
  • [ 119116-94-8 ]
  • [ 4265-16-1 ]
Reference: [1] Journal of Organic Chemistry, 2017, vol. 82, # 13, p. 6972 - 6977
  • 10
  • [ 108-95-2 ]
  • [ 4265-16-1 ]
Reference: [1] Medicinal Chemistry Research, 2016, vol. 25, # 3, p. 494 - 500
[2] Journal of Molecular Structure, 2018, vol. 1153, p. 119 - 127
[3] Pharmaceutical Chemistry Journal, 2018, vol. 51, # 10, p. 893 - 901
  • 11
  • [ 108-98-5 ]
  • [ 4265-16-1 ]
Reference: [1] Organic Letters, 2017, vol. 19, # 7, p. 1646 - 1649
  • 12
  • [ 533-58-4 ]
  • [ 4265-16-1 ]
Reference: [1] Organic Letters, 2017, vol. 19, # 11, p. 2865 - 2868
  • 13
  • [ 74401-08-4 ]
  • [ 4265-16-1 ]
Reference: [1] Chemische Berichte, 1985, vol. 118, # 12, p. 4674 - 4681
[2] European Journal of Medicinal Chemistry, 1983, vol. 18, # 4, p. 353 - 358
  • 14
  • [ 76268-18-3 ]
  • [ 4265-16-1 ]
Reference: [1] Journal of the Indian Chemical Society, 1980, vol. 57, # 6, p. 633 - 636
  • 15
  • [ 50635-12-6 ]
  • [ 4265-16-1 ]
Reference: [1] Nippon Kagaku Zasshi, 1953, vol. 74, p. 636[2] Chem. Zentralbl., 1954, vol. 125, p. 12071
  • 16
  • [ 42974-19-6 ]
  • [ 4265-16-1 ]
Reference: [1] Journal of the Indian Chemical Society, 1980, vol. 57, # 6, p. 633 - 636
  • 17
  • [ 496-41-3 ]
  • [ 4265-16-1 ]
Reference: [1] Helvetica Chimica Acta, 1930, vol. 13, p. 1275,1280
[2] Helvetica Chimica Acta, 1930, vol. 13, p. 1275,1280
[3] Helvetica Chimica Acta, 1930, vol. 13, p. 1275,1280
  • 18
  • [ 41717-28-6 ]
  • [ 4265-16-1 ]
Reference: [1] Helvetica Chimica Acta, 1930, vol. 13, p. 1275,1280
[2] Helvetica Chimica Acta, 1930, vol. 13, p. 1275,1280
[3] Helvetica Chimica Acta, 1930, vol. 13, p. 1275,1280
  • 19
  • [ 39685-86-4 ]
  • [ 4265-16-1 ]
Reference: [1] Helvetica Chimica Acta, 1930, vol. 13, p. 1275,1280
  • 20
  • [ 4265-25-2 ]
  • [ 4265-16-1 ]
Reference: [1] Bulletin de la Societe Chimique de France, 1945, vol. <5> 12, p. 609,615
  • 21
  • [ 7252-83-7 ]
  • [ 90-02-8 ]
  • [ 4265-16-1 ]
Reference: [1] Russian Chemical Bulletin, 2007, vol. 56, # 2, p. 325 - 329
  • 22
  • [ 7446-08-4 ]
  • [ 64-17-5 ]
  • [ 4265-25-2 ]
  • [ 4265-16-1 ]
Reference: [1] Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences, 1944, vol. 218, p. 683[2] Bulletin de la Societe Chimique de France, 1945, vol. <5> 12, p. 609,612
  • 23
  • [ 271-89-6 ]
  • [ 68-12-2 ]
  • [ 10025-87-3 ]
  • [ 4265-16-1 ]
Reference: [1] Journal of the Chemical Society, 1955, p. 3688,3692
  • 24
  • [ 4265-16-1 ]
  • [ 66158-96-1 ]
Reference: [1] Patent: US6465467, 2002, B1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 4265-16-1 ]

Aldehydes

Chemical Structure| 10035-16-2

[ 10035-16-2 ]

Benzofuran-5-carbaldehyde

Similarity: 0.86

Chemical Structure| 120973-72-0

[ 120973-72-0 ]

2-Benzoylbenzofuran-5-carbaldehyde

Similarity: 0.84

Chemical Structure| 1504-74-1

[ 1504-74-1 ]

2-Methoxycinnamaldehyde

Similarity: 0.83

Chemical Structure| 53355-29-6

[ 53355-29-6 ]

Methyl 4-(5-formylfuran-2-yl)benzoate

Similarity: 0.80

Chemical Structure| 1700-37-4

[ 1700-37-4 ]

3-Benzyloxybenzaldehyde

Similarity: 0.80

Related Parent Nucleus of
[ 4265-16-1 ]

Benzofurans

Chemical Structure| 10242-08-7

[ 10242-08-7 ]

5-Methoxybenzofuran-2-carboxylic acid

Similarity: 0.88

Chemical Structure| 10035-16-2

[ 10035-16-2 ]

Benzofuran-5-carbaldehyde

Similarity: 0.86

Chemical Structure| 82788-37-2

[ 82788-37-2 ]

Methyl 6-methylbenzofuran-2-carboxylate

Similarity: 0.85

Chemical Structure| 24673-56-1

[ 24673-56-1 ]

3-Methylbenzofuran-2-carboxylic acid

Similarity: 0.85

Chemical Structure| 3199-61-9

[ 3199-61-9 ]

Ethyl benzofuran-2-carboxylate

Similarity: 0.84